Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1405 of 5804
-
Smart radiotherapy aims to cut cancer treatment side effects
Symptom relief Recruiting nowRadiotherapy of head-neck cancer is associated with significant side effects. Using daily online adaptive radiotherapy to account for the changing anatomy, radiation to organs at risk can be lowered. We will investigate whether this is feasible and associated with a reduction in …
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Could a Parkinson's drug help depressed people feel pleasure again?
Symptom relief Recruiting nowThe purpose of this 8-week, double-blind, placebo-controlled, study is to explore new treatment options for people with depression who have high inflammation and anhedonia. Seventy male and female participants with depression, between 25-55 years of age, with higher levels of inf…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could your own immune cells fight Alzheimer's? new trial launches
Disease control Recruiting nowThe goal of this clinical trial is to test SNK01 in participants with moderate Alzheimer's Disease. The main questions it aims to answer are: 1. Is SNK01 safe and tolerable when administered every 3 weeks for up to 1 year as an intravenous infusion 2. Can SNK01 administration im…
Phase: PHASE1, PHASE2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Which sedation is safer for stroke patients during clot removal?
Symptom relief Recruiting nowThis study aims to conduct a multicenter, prospective, randomized clinical trial to scientifically evaluate the safety and efficacy of different perioperative sedation methods during endovascular thrombectomy in acute ischemic stroke patients with large vessel occlusion in the an…
Phase: PHASE4 • Sponsor: Jinling Hospital, China • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Could a common nerve pain drug help control HIV and curb heavy drinking?
Disease control OngoingGRAIL is a Randomized Controlled Trial (RCT) among 300 HIV-positive persons with heavy alcohol consumption (by NIAAA definition) who have had detectable HIV viral load (HVL) at least 6 months after their HIV diagnosis. This trial aims to test the efficacy of gabapentin versus pla…
Phase: PHASE2 • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
AI spots heart disease from your face alone
Diagnosis CompletedThe goal of this observational study are 1) to assess the effectiveness of modalities and/or their combination of multimodal non-contact information in predicting coronary artery disease; 2) to prospectively validate the performance of the developed artificial Intelligence models…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Scientists hunt for hidden clues to stop a deadly pregnancy complication
Knowledge-focused Recruiting nowPreeclampsia (PE) is a major obstetric complication with short- and long-term consequences for the mother and the fetus. Early screening tools to reduce its mortality and morbidity, as well as to prevent the life-threatening consequences are needed. Thus, the detection of women a…
Sponsor: Carlos Simon Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Parenting class may sharpen preschoolers' self-control and reduce behavior problems
Disease control Recruiting nowDeficits in executive functioning (EF) disproportionately impact children living in poverty and increase risk for psychopathology, particularly disruptive behavior disorders. This randomized clinical trial seeks to determine whether childhood EF, assessed across neural and behavi…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Sound waves vs. prostate cancer: new MRI-Guided treatment tested
Disease control Recruiting nowBackground: The ability to treat early prostate cancer is still limited. Thermal ablation methods are being tested for focal prostate cancer therapy. Researchers want to improve on these methods. Objective: To understand if Transurethral UltraSound Ablation (TULSA) in combinat…
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New RSV pill shows promise in early human trial
Disease control CompletedA randomized, Phase 2a, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and antiviral activity of multiple doses of orally administered EDP-323 in healthy subjects infected with RSV-A Memphis 37b. This study is designed to assess the antiviral effe…
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New COVID-19 booster studied for vulnerable patients
⭐️ VACCINE ⭐️ CompletedTo determine whether providing a recombinant booster COVID-19 vaccine improves sustained humoral and cell-mediated immunogenicity against SARS-CoV-2 in immunosuppressed patients with Inflammatory Bowel Disease (IBD) and/or solid organ transplant recipients. 120 participants will …
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:55 UTC
-
Blood-based gels battle diabetic foot ulcers in head-to-head trial
Disease control CompletedThe goal of this randomized control trial is to compare the efficacy and safety of Platelet Rich Plasma VS Platelet Fibrin Plasma in patients with diabetes foot ulcer. The main question it aims to answer are: * Whether the Platelet Fibrin Plasma have noninferior efficacy than Pl…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for blood cancer patients in japan?
Disease control OngoingThe purpose of this study is to test the safety, tolerability, efficacy, and drug levels of BMS-986369 (Golcadomide) in participants with relapsed or refractory T-cell lymphomas in Japan (GOLSEEK-3).
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New DNA test could speed up pneumonia diagnosis in ICU patients
Diagnosis ENROLLING_BY_INVITATIONPneumonia, pathogen involved to lower respiratory tract and leading lung parenchyma infection, is one of the three most common infectious diseases in the world. Rapidly and correctly diagnosis and prescription could reduce the complication, length of hospitalization and mortality…
Sponsor: China Medical University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
AI takes aim at lung cancer: smarter radiation doses could reduce recurrence
Disease control Recruiting nowThis phase II trial tests the effectiveness and safety of artificial intelligence (AI) to determine dose recommendation during stereotactic body radiation therapy (SBRT) planning in patients with primary lung cancer or tumors that has spread from another primary site to the lung …
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New weight loss drug shows promise in early trial
Disease control CompletedThe main purpose of this study, performed under a master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with Mazdutide compared with placebo and in adult participants with obesity or overweight. The study will last about 62 weeks.
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Collagen thread boosts lymphedema surgery? stanford trial begins
Disease control Recruiting nowInvestigate whether the addition of the Biobridge scaffold to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper extremity. Will Biobridge improve upon the low success rate of the currently practiced…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a vaccine finally stop the 'Snail Fever'?
⭐️ VACCINE ⭐️ CompletedThe goal of this phase 1b, multicenter, randomized, placebo-controlled, observer-blinded, dose-escalation study is to assess the safety, tolerability, and immunogenicity of a three-dose regimen, spaced four weeks apart, given intramuscularly in healthy adults (20-59 years old). T…
Phase: PHASE1 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:25 UTC
-
Gum treatment may help fight Alzheimer's, small trial hints
Disease control ENROLLING_BY_INVITATIONPeriodontitis is the most prevalent chronic infectious inflammatory disease in adults, leading to the destruction of tooth-supporting tissues. Beyond its local impact, periodontitis contributes to systemic inflammation through the release of periodontal pathogens and their byprod…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental combo targets Hard-to-Treat pancreatic cancer
Disease control OngoingThis study is being done to test the safety and effectiveness of combining ZN-c3 and Gemcitabine in participants with pancreatic cancer. The names of the study drugs involved in this study are: * ZN-c3 (a small molecule inhibitor of the WEE1 tyrosine kinase) * Gemcitabine (a nu…
Phase: PHASE2 • Sponsor: Brandon Huffman, MD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC